Optellum was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage and cured. Our vision is to redefine early intervention of diseases like lung cancer, by enabling every clinician in every hospital to make the right decisions and give their patients the best chance to fight back.
Dr Václav Potěšil PhD, CEO of Optellum
Video courtesy of the Texas Medical Center
Optellum’s initial product is the Virtual Nodule Clinic, the first AI Clinical Decision Support software for lung cancer management. Our platform helps clinicians identify and track at-risk patients and speed up decisions for those with cancer while reducing unnecessary procedures.
Optellum’s solutions are based on Artificial Intelligence and Machine Learning technologies applied to the world’s largest clinical dataset. We are working to expand our platform to drive optimal decisions across the lung cancer patient journey and into the early diagnosis and treatment of other deadly diseases of the lungs.